Clinical Trial Update: Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial exploring metformin hydrochloride for preventing breast cancer in patients with atypical hyperplasia or in situ breast cancer; status ACTIVE_NOT_R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Ductal Breast Hyperplasia
• Brca1 Mutation Carrier
• Brca2 Mutation Carrier
• Ductal Carcinoma in Situ
• Lobular Carcinoma in Situ

Drugs mentioned

• METFORMIN HYDROCHLORIDE (Metformin hydrochloride)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Atypical Ductal Breast Hyperplasia, BRCA1 Mutation Carrier | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-04-13